Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

Cetuximab and cisplatin/5-FU (CF) versus CF in first-line metastatic squamous cell carcinoma of the esophagus (MESCC): A randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.4546 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 4546-4546 ◽

Cited By ~ 2

Author(s):

F. Lordick ◽

S. Lorenzen ◽

S. Al-Batran ◽

R. Hofheinz ◽

P. C. Thuss-Patience ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

First Line ◽

Carcinoma Of The Esophagus ◽

Randomized Phase Ii ◽

A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2081-5 ◽

2013 ◽

Vol 71 (4) ◽

pp. 905-911 ◽

Cited By ~ 17

Author(s):

Jialei Wang ◽

Jianhua Chang ◽

Hui Yu ◽

Xianghua Wu ◽

Huijie Wang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

First Line ◽

Carcinoma Of Esophagus ◽

Line Chemotherapy

Faculty Opinions recommendation of Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13355993.791652823 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Faculty Opinions recommendation of Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13355993.14726100 ◽

2011 ◽

Author(s):

Jan Vermorken

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) previously treated with platinum-based therapy.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.6051 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 6051-6051

Author(s):

Sylvie Rottey ◽

Aline Van Maanen ◽

Jean-Marie Vandenbulcke ◽

Bertrand Filleul ◽

Emmanuel Seront ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Previously Treated

Randomized Phase Ii Study of Mehd7945A (Mehd) Vs Cetuximab (Cet) in >= 2Nd-Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck (Rmscchn) Progressive On/After Platinum-Based Chemotherapy (Ptct)

Annals of Oncology ◽

10.1093/annonc/mdu340.1 ◽

2014 ◽

Vol 25 ◽

pp. iv340 ◽

Cited By ~ 19

Author(s):

J. Fayette ◽

L.J. Wirth ◽

C. Oprean ◽

R. Hitt ◽

A. Udrea ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Platinum Based Chemotherapy ◽

Head Neck

912P Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1322 ◽

2021 ◽

Vol 32 ◽

pp. S807-S808

Author(s):

V. Gruenwald ◽

U. Graeven ◽

P. Ivanyi ◽

A. Dietz ◽

D. Hahn ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study

BMC Cancer ◽

10.1186/s12885-015-1716-9 ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 5

Author(s):

Su Jin Lee ◽

Sungmin Kim ◽

Moonjin Kim ◽

Jeeyun Lee ◽

Yeon Hee Park ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum‐Based Therapy

The Oncologist ◽

10.1634/theoncologist.2016-0296 ◽

2016 ◽

Vol 21 (12) ◽

pp. 1416 ◽

Cited By ~ 7

Author(s):

Jean‐Pascal Machiels ◽

Aline Van Maanen ◽

Jean‐Marie Vandenbulcke ◽

Bertrand Filleul ◽

Emmanuel Seront ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Previously Treated

A phase II study of nedaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus: The Japan Clinical Oncology Group (JCOG) Trial (JCOG 9905-DI)

Esophagus ◽

10.1007/s10388-014-0427-7 ◽

2014 ◽

Vol 11 (3) ◽

pp. 183-188 ◽

Cited By ~ 16

Author(s):

Ken Kato ◽

◽

Kei Muro ◽

Nobutoshi Ando ◽

Tadashi Nishimaki ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Clinical Oncology ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Carcinoma Of The Esophagus ◽